- Blog
- News & Media
- Issues
- About The Biopharmaceutical Sector
- Access and Affordability
- Adherence
- Appropriate Use Of Medicines
- Counterfeit Drugs
- Disaster Response
- Drug Safety
- Environmental Issues
- Food And Drug Administration
- Importation
- Intellectual Property
- International
- Medical Advances
- Medicare
- Prescription Drug Abuse
- Prescription Drug User Fee Act
- Sales And Marketing
- Value of Medicines
- Research
- About
J. Martin Carroll talks Innovation, Alzheimer's
Boehringer Ingelheim USA Corporation President & CEO J. Martin Carroll talks Innovation and the work being done to find effective treatments and cures to Alzheimer's disease in our lifetime.
